Evaluating the value of genomic sequencing for diagnosing rare diseases in children
Official title: Surfacing values in the economic evaluation of genomic sequencing for diagnosis of children with rare diseases
Funded at Stanford University · NIH-11032010 · Data updated 2026-11-12
This study is looking at how using genetic testing can help find out what's causing rare diseases in kids, and it wants to hear from families and doctors to make sure it's helpful and fair for everyone involved.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project start | May 10, 2021 |
| Project end | February 28, 2026 |
| Funding year | 2025 |
| Award (this year) | $117,063 |
| NIH project number | 5K01HG011341-05 |
| Project ID | NIH-11032010 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are children under 12 years old who are suspected of having rare diseases and have not yet received a diagnosis.
✕Less likely to help
Patients with well-defined diagnoses or those outside the pediatric age range may not benefit from this research.
What this research studies
This research investigates how genomic sequencing can help diagnose rare diseases in children, aiming to understand its benefits and costs for patients and families. It focuses on gathering insights from various stakeholders, including patients, families, and healthcare providers, to ensure that the evaluation methods are both accurate and ethical. By identifying the potential impacts of genomic sequencing, the research seeks to improve decision-making in healthcare regarding its use for pediatric patients with rare diseases.
Why it matters
Potential benefit: If successful, this research could lead to better understanding and improved access to genomic sequencing for diagnosing rare diseases in children.
How similar studies have gone: Previous research has shown promising results in using genomic sequencing for diagnosing rare diseases, indicating that this approach has potential for success.
Where this research is happening
-
Stanford University
Stanford, United States Active
Researchers
- Principal investigator: Halley, Meghan — Stanford University
- Study coordinator: Halley, Meghan
Related research
Other NIH-funded projects on the same topics.
-
Liver pathobiology from rare liver diseases
A study at UCSF looks at why rare liver conditions cause liver damage, with the aim of finding new ways to diagnose and treat chronic liver disease.
-
Data Management and Coordinating Center support for Rare Diseases Research
A national rare diseases research program is funding a center to manage data and coordinate studies to help improve diagnosis, care, and potential treatments for children with rare conditions.
-
EEG-based drug repurposing for rare CNS diseases
A new approach uses EEG brain signatures to find existing drugs that might help people with rare nervous-system disorders.
-
Ethics of Engaging Patient Groups in Drug Development for Rare Diseases
This grant asks how patient and family groups can ethically help shape rare-disease drug development from idea to market, with input from patients, families, doctors, and researchers.
-
Center for Polyamine Disorders group study of rare metabolic disorders
A research consortium is studying a group of rare metabolic disorders linked to polyamines and aims to understand symptoms, biomarkers, and disease progression to improve care.
-
Encore: speeding up finding new uses for existing drugs to help kids with rare diseases
A big NIH project will test thousands of existing medicines to see if any can help treat rare genetic diseases in children.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.